• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Juno Explodes on Celgene Takeover Rumors biospace
    January 18, 2018
    Rumors that Celgene Corporation is in talks to acquire Juno Therapeutics has caused Juno’s stock to rocket more than 50 percent to $68.80 in premarket trading.
  • Juno ends development of CAR-T therapy JCAR015 following patient deaths firstwordpharma
    March 03, 2017
    Juno Therapeutics said that it will end development of the experimental CAR-T therapy JCAR015 in adults with relapsed or refractory acute lymphoblastic leukaemia (ALL) following safety issues observed in a mid-stage trial.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service